Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Slovin, SF; Knudsen, KE; Carbone, E; Showunmi, A; Hullings, M; Morris, MJ; Autio, KA; Kampel, LJ; Molina, AM; Chen, Y; Arauz, G; Curley, T; Tse, K; Halabi, S; Scher, HI; Kelly, WK

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • TPS5093 - TPS5093

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.tps5093